Abbott Laboratories (NYSE:ABT)
Abbott Laboratories
NYSE:ABT
P/E
Price to Earnings
The Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
= Market Cap
/ Net Income
Current P/E
ABT
25
Median P/E
ABT
40.3
Industry P/E
Health Care
18.1
P/E History
Statistics
Price to Earnings
Price to Earnings
| 1 Year | 3 Years | 5 Years | |
|---|---|---|---|
| Average | 30.6 | 40.8 | 67.7 |
| Median | 31.2 | 40.3 | 48.9 |
| Min | 25.8 | 25.8 | 25.8 |
| Max | 35 | 59.1 | 215.7 |
History Chart
Price to Earnings
Price to Earnings
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
22.4
2-Years Forward
P/E
22.4
3-Years Forward
P/E
20
P/E Across Competitors
ABT Competitors
Abbott Laboratories Competitors
Abbott Laboratories Competitors
Relative Valuation Report
View full relative valuation report for Abbott Laboratories, which takes into account all ABT`s valuation multiples.
